Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Association of Vimentin overexpression and hepatocellular carcinoma metastasis

Abstract

The poor prognosis of hepatocellular carcinoma (HCC) has been associated with recurrence and metastasis. Recently, we established a pair of HCC cell lines from a primary (H2-P) and its matched metastatic (H2-M) HCC tumors. A high density of cDNA microarray with 9184 human cDNA was used to identify the differentially expressed genes between H2-P and H2-M. Comparing with H2-P, eight upregulated and six downregulated genes were detected in H2-M. One interesting finding is the overexpression of Vimentin (VIM), a well-defined intermediate filament, which has been linked to a more aggressive status in various tumors. The correlation of overexpression of VIM and HCC metastasis was studied by immunohistochemistry using a tissue microarray with 200 primary HCCs and 60 pairs of primary and matched metastatic HCC samples. Tissue microarray demonstrated that the overexpression of VIM was significantly associated with HCC metastasis (P<0.01). This finding strongly suggests that the overexpression of VIM may play an important role in the metastasis of HCC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Aguayo A and Patt YZ . (2001). Semin. Oncol., 28, 503–513.

  • Aldamassi M, Chen Z, Merriman B, Gussin D and Nelson S . A Practical Guide to Microarray Analysis of Gene Expression. UCLA Microarray Core & Nelson Lab, UCLA Department of Human Genetics, Revision #3, September 21, 2001 (available at http://www.genetics.ucla.edu/microarray).

  • Ben Ze'ev A and Raz A . (1985).Cancer Res., 45, 2632–2641.

  • Byrne JA, Mattei MG and Basset P . (1996). Genomics, 35, 523–532.

  • Deo RC, Bonanno JB, Sonenberg N and Burley SK . (1999). Cell, 98, 835–845.

  • Domagala W, Striker G, Szadowska A, Dukowicz A, Harezga B and Osborn M . (1994). Eur. J. Cancer, 30A, 1527–1534.

  • Fan C, Stendahl U, Stjernberg N and Beckman L . (1995). Oncology, 52, 498–500.

  • Gilles C, Polette M, Piette J, Delvigne AC, Thompson EW, Foidart JM and Birembaut P . (1996). J. Pathol., 180, 175–180.

  • Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, Foidart JM and Birembaut P . (1999). J. Cell Sci., 112, 4615–4625.

  • Guan X-Y, Zhang HE, Bitter M, Jiang Y, Meltzer PS and Trent JM . (1996). Nat. Genet., 12, 10–11.

  • Guan X-Y, Fang Y, Sham JST, Kwong DLW, Zhang Y, Liang Q, Li H, Zhou H and Trent JM . (2000). Genes Chromosomes Cancer, 29, 110–116.

  • Hendrix MJ, Seftor EA, Seftor RE and Trevor KT . (1997). Am. J. Pathol., 150, 483–495.

  • Iwatsuki H, Sasaki K, Suda M and Itano C . (1999). Acta. Histochem., 101, 369–382.

  • Lang SH, Hyde C, Reid IN, Hitchcock IS, Hart CA, Bryden AA, Villette JM, Stower MJ and Maitland NJ . (2002). Prostate, 52, 253–263.

  • Laroia G, Cuesta R, Brewer G and Schneider RJ . (1999). Science, 284, 499–502.

  • Lelievre V, Pineau N, Hu Z, Ioffe Y, Byun JY, Muller JM and Waschek JA . (2001). J. Biol. Chem., 276, 43668–43676.

  • Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP and Sauter G . (1999). Am. J. Pathol., 154, 981–986.

  • Qin L-X, Tang Z-Y, Sham JST, Ma Z-C, Ye S-L, Zhou X-D, Wu Z-Q, Trent JM and Guan X-Y . (1999). Cancer Res., 59, 5662–5665.

  • Redondo M, Villar E, Torres-Muñoz J, Tellez T, Morell M and Petito C . (2000). Am. J. Pathol., 157, 393–399.

  • Tang ZY . (2001). World J. Gastroenterol., 7, 445–454.

  • Thomas-Salgar S, Millis AJ . (1994). J. Biol. Chem., 269, 17879–17885.

  • Vieira HL, Haouzi D, El Hamel C, Jacotot E, Belzacq AS, Brenner C and Kroemer G . (2000). Cell Death Differ., 7, 1146–1154.

  • Wang Y, Wu M-C, Sham JST, Tai L-S, Fang Y, Wu W-Q, Xie D and Guan X-Y . (2002). J. Pathol., 197, 610–616.

  • Wen JM, Huang JF, Hu L, Wang W, Zhang M, Sham JST, Xu J, Zeng W-F, Xie D, Liang L and Guan X-Y . (2002). Cancer Genet. Cytogenet., 135, 91–95.

Download references

Acknowledgements

This work was supported by a Research Grant Council Grant HKU7236/00M and Leung Kwok Tze Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xin-Yuan Guan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, L., Lau, S., Tzang, CH. et al. Association of Vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene 23, 298–302 (2004). https://doi.org/10.1038/sj.onc.1206483

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206483

Keywords

This article is cited by

Search

Quick links